Rosacea Update

MIRVASO® (brimonidine) topical gel, 0.33%* is the first and only FDA-approved treatment developed and indicated for persistent facial redness of rosacea. Facial redness is a common symptom of rosacea, a skin condition that affects an estimated 16 million Americans.

 

Galderma_BeforeAfter_-Mirvaso

Contact Dr Clayton for further information….

Vamtam
Vamtam

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor

New Clinic in North Wales

Dr Clayton is delighted to announce that he has joined a team of colleagues in North Wales to help deliver private dermatology clinics in the

New TV Show

Last year I took part in a BBC1 series looking at skin problems affecting young people. The program was filmed over several weeks at a